Search Ontology:
ChEBI

zavegepant

Term ID
CHEBI:229643
Synonyms
  • (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide
  • BHV 3500
  • BHV-3500
  • BHV3500
  • BMS 742413
  • BMS-742413
  • BMS-742413-01
  • N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl}-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide
  • zavegepant
  • zavegepantum
Definition
A member of the class of ureas that is urea in which both amino groups are replaced by 4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidin-1-yl and {(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl}amino groups. It is a calcitonin gene-related peptide receptor antagonist whose hydrochloride salt has been approved by the FDA for the acute treatment of migraine.
References
  • cas:1337918-83-8
  • drugbank:DB15688
  • kegg.drug:D11898
  • patent:US2012059017
  • pubmed:23632269
  • pubmed:33096162
  • pubmed:35774914
  • pubmed:36189708
  • pubmed:36239038
  • pubmed:36552072
  • pubmed:36804093
  • pubmed:37012363
  • pubmed:37094060
  • pubmed:37227596
  • pubmed:37270693
  • pubmed:37345774
  • pubmed:37363553
  • pubmed:37593294
  • pubmed:37630989
  • pubmed:37723470
  • pubmed:37897226
  • pubmed:37904462
  • pubmed:38311738
  • pubmed:38333255
  • wikipedia.en:Zavegepant
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from zavegepant
Phenotype where environments contain zavegepant
Phenotype modified by environments containing zavegepant
Phenotype affecting zavegepant
Human Disease Model